Covid-19: the vaccine
Pfizer-BioNTech neutralizes a
"Key mutation" of variants
BioNTech-Pfizer's Covid-19 vaccine
seems effective against a "Key mutation"
British and South African variants of
coronavirus, seton the result of work
communicated on Friday by the BioNTech laboratory.
<The antibodies of people who received the vaccine
NTech Covid-19 effectively neutralizes Sars-CoV-2
ave: a Key mutation which is also found in two strains
Covid-19:
t transmissible 'identified in Great Britain and
South Africa, says the laboratory in its press release.
limits of this brief study, underlined by
Covid-19: the vaccine
themselves is that it is not about
'-BioNTech neutralize a
variants
All of the mutations present in these variants.
In France, a cluster at risk of the British variant
been detected in ile-de-France. The new strain has been identified
an individual who turns out to be a school leader
speaker in Bagneux nursery school.
At the same time, the European Agency for
drug (EMA) Has just changed its
recommendations for the Pfizer-BioNTech vaccine,
indicating in a press release Friday, January 8 that
the single vial contained six doses. And not five like
To do this, special canisters must
be used, as it is possible that
standard syringes do not allow to extract
the sixth dose from a vial, the EMA said.
Using an additional dose will allow
speed up vaccination campaigns in Europe
Covid-19, the vaccine, Pfizer-BioNTech, neutralizes, a Key, mutation, of variants,